Article

Mosaic receptor-binding domain nanoparticles induce protective immunity against SARS-CoV-2 challenges

2022-02-18

Abstract excerpt

Recurrent spillovers of α- and β-coronaviruses (CoV) such as acute respiratory syndrome (SARS)-CoV, Middle East respiratory syndrome (MERS)-CoV, SARS-CoV-2, and possibly human CoV (NL63, 229E, OC43, and HKU1) have caused serious morbidity and mortality worldwide. Six receptor binding domains (RBDs) derived from α- and β-CoV that are considered to have originated from animals and cross-infected humans were linked t...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: f2a4ed68-59db-5298-bccf-ed6f8e8387a1
DOI: 10.1101/2022.02.18.480994

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Mosaic receptor-binding domain nanoparticles induce protective immunity against SARS-CoV-2 challengesDOI 10.1101/2022.02.18.480994Read

Mosaic RBD nanoparticles induce intergenus cross-reactive antibodies and protect against SARS-CoV-2 challengeSemantic proximity Read

Rational Design of Multiclade Coronavirus Spike Immunodominant Domain Nanoparticles to Elicit Broad Antibody ResponsesSemantic proximity Read

Broad-spectrum coronavirus neutralization induced by hetero RBD-Fc protein vaccineSemantic proximity Read

Immunization With a RBD/Nucleocapsid Fusion Protein Promotes Neutralizing Antibody-Independent Resistance to the Wild-Type and the Delta Variant of SARS-CoV-2Semantic proximity Read

A bivalent nanoparticle vaccine exhibits potent cross-protection against the variants of SARS-CoV-2Semantic proximity Read

Neutralizing monoclonal antibodies elicited by mosaic RBD nanoparticles bind conserved sarbecovirus epitopesSemantic proximity Read

CoVac501, a self-adjuvanting peptide vaccine conjugated with TLR7 agonists, against SARS-CoV-2 induces protective immunitySemantic proximity Read

A Potent Bispecific Nanobody Protects hACE2 Mice Against SARS-CoV-2 Infection via Intranasal AdministrationSemantic proximity Read

Phylogeny-driven design of broadly protective sarbecovirus receptor-binding domain nanoparticle vaccinesSemantic proximity Read

DNA origami presenting the receptor binding domain of SARS-CoV-2 elicit robust protective immune responseSemantic proximity Read

A Novel Double Mosaic Virus-like Particle-Based Vaccine against SARS-CoV-2 Incorporates Both Receptor Binding Motif (RBM) and Fusion DomainSemantic proximity Read

A potent bispecific nanobody protects hACE2 mice against SARS-CoV-2 infection via intranasal administrationSemantic proximity Read